Aptevo Therapeutics Inc. (APVO) vs Dermata Therapeutics, Inc. (DRMA)
A side-by-side comparison of Aptevo Therapeutics Inc. and Dermata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.84HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
DRMA
Dermata Therapeutics, Inc.
$1.15HealthcareDelayed quote: Oct 6, 2026, 1:42 PM EDT
Total return — APVO vs DRMA
growth of $100 · dividends reinvested · last 5yAPVO -100.0% (-95.4%/yr)DRMA -100.0% (-84.5%/yr)DRMA compounded faster over this window
Log scale — wide-divergence pair
APVO DRMA
APVO vs DRMA: by the numbers
- •DRMA is the larger company ($5M vs $4M market cap).
Metrics side by side
Valuation
| Metric | APVO | DRMA |
|---|---|---|
| P/B ratio | 0.67 | 1.32 |
Profitability
| Metric | APVO | DRMA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -437.15% | -239.95% |
| ROIC | -288.14% | -246.61% |
Growth (annualized)
| Metric | APVO | DRMA |
|---|---|---|
| Total return CAGR (5Y) | -95.30% | -83.90% |
Frequently asked
- How have APVO and DRMA total returns compared?
- Over the past 5 years, APVO delivered -95.30% and DRMA delivered -83.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.